ArticleFrontiers in immunology2025

Toripalimab plus chemotherapy versus chemotherapy as first-line therapy for extensive-stage small cell lung cancer: a cost-effectiveness analysis.

Longfeng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.